223 related articles for article (PubMed ID: 16427387)
1. Massive transfusion coagulopathy.
Levy JH
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S59-63. PubMed ID: 16427387
[TBL] [Abstract][Full Text] [Related]
2. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
3. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Tomita E; Takase H; Tajima K; Suematsu Y
Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
[TBL] [Abstract][Full Text] [Related]
4. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
5. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
7. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
9. Update on Novo Nordisk's clinical trial programme on NovoSeven.
Dejgaard A
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S39-41. PubMed ID: 14567535
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
11. Ultra-early hemostatic therapy for acute intracerebral hemorrhage.
Mayer SA; Rincon F
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S70-6. PubMed ID: 16427389
[TBL] [Abstract][Full Text] [Related]
12. [Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
Martínez Rodríguez E; Mato M; Otero J; Ferri JR; Gonzálvez A; Torres LM
Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):195-7. PubMed ID: 16671265
[No Abstract] [Full Text] [Related]
13. Pediatric off-label use of recombinant factor VIIa.
Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
[TBL] [Abstract][Full Text] [Related]
14. Bleeding and management of coagulopathy.
Sniecinski RM; Levy JH
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):662-7. PubMed ID: 21549397
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII and the anaesthetist.
Welsby IJ; Monroe DM; Lawson JH; Hoffmann M
Anaesthesia; 2005 Dec; 60(12):1203-12. PubMed ID: 16288618
[TBL] [Abstract][Full Text] [Related]
16. [Recombinant activated factor VII used in a man with refractory bleeding from a stab wound injuring the liver and kidney].
Arnal D; Piñeiro P; Garutti I; Olmedilla L; Sanz J; Lajara A
Rev Esp Anestesiol Reanim; 2004 May; 51(5):284-8. PubMed ID: 15214766
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
Hedner U
Semin Hematol; 2001 Oct; 38(4 Suppl 12):43-7. PubMed ID: 11735110
[TBL] [Abstract][Full Text] [Related]
18. [Use of "NovoSeven" (rFVIIa) hemostatic in patients operated with extracorporeal blood circulation].
Dement'eva II; Sandrikov VA; Charnaia MA; Morozov IuA; Trekova NA; Eremenko AA
Anesteziol Reanimatol; 2004; (5):11-3. PubMed ID: 15573716
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of recombinant factor VIIa.
Roberts HR; Monroe DM; Hoffman M
Semin Hematol; 2004 Jan; 41(1 Suppl 1):101-8. PubMed ID: 14872430
[TBL] [Abstract][Full Text] [Related]
20. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
